Literature DB >> 18537816

The susceptibility to vitiligo is associated with NF-E2-related factor2 (Nrf2) gene polymorphisms: a study on Chinese Han population.

Cui-Ping Guan, Miao-Ni Zhou, Ai-E Xu, Ke-Fei Kang, Ji-Feng Liu, Xiao-Dong Wei, Yong-Wei Li, De-Kuang Zhao, Wei-Song Hong.   

Abstract

Vitiligo is an acquired pigmentary disorder and its pathogenesis remains unclear. Oxidative stress is considered to be the initial pathogenic event in the melanocyte destruction. NF-E2-related factor2 (Nrf2) is a transcription factor regulating the expression of detoxifying and antioxidant genes. To investigate the association of the Nrf2 gene promoter polymorphisms with vitiligo in Chinese Han population, the genotypes of -686A/G, -684G/A and -650C/A and the genotyping of variable number of tandem repeat were detected. The data were analysed by the chi-square test and the risk was evaluated by calculating OR and 95% CI. There was statistically significant difference in genotypic and allelic frequencies of -650C/A between the two groups (P < 0.05). A(-650) allele was significantly associated with the risk for vitiligo (OR = 1.724, chi(2) = 18.096). Polymorphism of the Nrf2 gene promoter at -650C/A was associated with the development of vitiligo and A(-650) allele may be one of the risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537816     DOI: 10.1111/j.1600-0625.2008.00752.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  19 in total

1.  Genetic variation in the Nrf2 promoter associates with defective spermatogenesis in humans.

Authors:  Bolan Yu; Huanlan Lin; Lixia Yang; Kang Chen; Haihua Luo; Jianqiao Liu; Xingcheng Gao; Xuefeng Xia; Zhaofeng Huang
Journal:  J Mol Med (Berl)       Date:  2012-05-31       Impact factor: 4.599

Review 2.  Stress-activated cap'n'collar transcription factors in aging and human disease.

Authors:  Gerasimos P Sykiotis; Dirk Bohmann
Journal:  Sci Signal       Date:  2010-03-09       Impact factor: 8.192

3.  Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP.

Authors:  Stanca A Birlea; Ying Jin; Dorothy C Bennett; Deborah M Herbstman; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanja van Geel; Jo Lambert; Andreas Overbeck; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2010-11-18       Impact factor: 8.551

Review 4.  Functional polymorphisms in Nrf2: implications for human disease.

Authors:  Hye-Youn Cho; Jacqui Marzec; Steven R Kleeberger
Journal:  Free Radic Biol Med       Date:  2015-06-25       Impact factor: 7.376

5.  Apigenin protects human melanocytes against oxidative damage by activation of the Nrf2 pathway.

Authors:  Baoxiang Zhang; Jing Wang; Guodong Zhao; Mao Lin; Yong Lang; Diancai Zhang; Dianqin Feng; Caixia Tu
Journal:  Cell Stress Chaperones       Date:  2020-01-18       Impact factor: 3.667

6.  Sex-, Age-, and Race/Ethnicity-Dependent Variations in Drug-Processing and NRF2-Regulated Genes in Human Livers.

Authors:  Jie Liu; Julia Yue Cui; Yuan-Fu Lu; J Christopher Corton; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2020-11-08       Impact factor: 3.922

7.  Nrf2 is required for normal postnatal bone acquisition in mice.

Authors:  Jung-Hyun Kim; Vandana Singhal; Shyam Biswal; Rajesh K Thimmulappa; Douglas J DiGirolamo
Journal:  Bone Res       Date:  2014-11-11       Impact factor: 13.567

Review 8.  The role of transcription factor Nrf2 in skin cells metabolism.

Authors:  Agnieszka Gęgotek; Elżbieta Skrzydlewska
Journal:  Arch Dermatol Res       Date:  2015-02-24       Impact factor: 3.017

Review 9.  Melanocytes as instigators and victims of oxidative stress.

Authors:  Laurence Denat; Ana L Kadekaro; Laurent Marrot; Sancy A Leachman; Zalfa A Abdel-Malek
Journal:  J Invest Dermatol       Date:  2014-02-27       Impact factor: 8.551

Review 10.  Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2.

Authors:  Hye-Youn Cho
Journal:  Oxid Med Cell Longev       Date:  2013-07-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.